AGIOS PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $1.29B | $203.1M |
| FY2022 | — | $1.10B | $139.3M |
| FY2023 | — | $811.0M | $88.2M |
| FY2024 | — | $1.54B | $76.2M |
| FY2025 | — | $1.19B | $89.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $1.29B | $203.1M |
| FY2022 | — | $1.10B | $139.3M |
| FY2023 | — | $811.0M | $88.2M |
| FY2024 | — | $1.54B | $76.2M |
| FY2025 | — | $1.19B | $89.1M |